XML 45 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 12, 2018
Feb. 03, 2018
Aug. 01, 2017
Feb. 22, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Common stock shares reserved under stock option plan         19,400,765   19,400,765    
Accounts payable         $ 19,833   $ 19,833   $ 61,333
Research and development expense         45,683 $ 139,819 279,000 $ 363,785  
Harmel S. Rayat [Member]                  
Consideration per year for executive office space             1    
Mr. Sierchio [Member]                  
Common stock shares reserved under stock option plan       37,500          
Debt conversion converted instrument shares issued       22,711          
Mr. Sierchio [Member] | Series H [Member]                  
Common stock shares reserved under stock option plan       10,000          
Debt conversion converted instrument shares issued       7,418          
Mr. Sierchio [Member] | Series F [Member]                  
Common stock shares reserved under stock option plan       7,246          
Debt conversion converted instrument shares issued       4,899          
Dr. Gerlach [Member]                  
Accounts payable             17,640
Compensation expense for services         10,000 $ 7,020 28,540  
Dr. Gerlach [Member] | Series A [Member]                  
Common stock shares reserved under stock option plan 480,000                
Debt conversion converted instrument shares issued 457,480                
Mr. Bhogal [Member]                  
Individual owning issue and outstanding share percent             5.00%    
Kenneth Kirkland [Member]                  
Annual retainer payable         6,000   $ 6,000    
Joseph Sierchio [Member]                  
Annual retainer payable         6,000   6,000    
VAM [Member]                  
Compensation expenses for consulting services per year             120,000    
Consulting services expense         30,000 20,400 73,467 61,200  
Jatinder Bhogal [Member]                  
Increased consulting fee, monthly         6,800   6,800    
Pittsburgh Life Sciences Greenhouse [Member] | Corporate Research Agreement [Member]                  
Research and development expense     $ 171,595   85,798      
Thomas Bold [Member]                  
Common stock shares reserved under stock option plan   60,000              
Debt conversion converted instrument shares issued   44,083              
Thomas Bold [Member] | Chief Financial Officer [Member]                  
Common stock shares reserved under stock option plan   60,000              
Debt conversion converted instrument shares issued   44,086              
Kenneth Kirkland [Member]                  
Common stock shares reserved under stock option plan       50,000          
Debt conversion converted instrument shares issued       41,033          
Kenneth Kirkland [Member] | Equity Option [Member]                  
Common stock shares reserved under stock option plan       50,000          
Debt conversion converted instrument shares issued       41,033          
Satterlee [Member]                  
Legal fees         67,813 15,115 227,175 195,783  
Accounts payable         148,715   148,715   $ 30,000
StemCell Systems [Member]                  
Incurred expenses         $ 14,315 $ 39,708 $ 39,499 $ 146,538